Compare TV & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TV | IART |
|---|---|---|
| Founded | 1969 | 1989 |
| Country | Mexico | United States |
| Employees | 26599 | N/A |
| Industry | Broadcasting | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | N/A | 1996 |
| Metric | TV | IART |
|---|---|---|
| Price | $2.78 | $17.63 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | $5.30 | ★ $14.33 |
| AVG Volume (30 Days) | 924.7K | ★ 1.0M |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.83% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.39 |
| Revenue Next Year | N/A | $3.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.27 | $8.70 |
| 52 Week High | $3.49 | $20.49 |
| Indicator | TV | IART |
|---|---|---|
| Relative Strength Index (RSI) | 50.86 | 49.34 |
| Support Level | $2.61 | $17.01 |
| Resistance Level | $2.83 | $18.92 |
| Average True Range (ATR) | 0.10 | 1.14 |
| MACD | 0.01 | -0.30 |
| Stochastic Oscillator | 59.09 | 42.70 |
Televisa is one of the leading telecom firms in Mexico. Its cable arm, Izzi, holds networks that pass 20 million Mexican homes and provide broadband service to nearly 6 million customers. The firm is also one of the largest pay-television providers in Mexico, with nearly 4 million customers. Televisa owns Sky Mexico, the country's only satellite-TV provider, serving about 4 million customers. After merging its traditional media business into Univision, Grupo Televisa owns a 43% stake in the combined entity TelevisaUnivision. Grupo Televisa spun off several smaller businesses, including magazine publishing, three of Mexico's professional soccer teams, and Azteca Stadium in February 2024, under the name Ollamani.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.